Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 66

1.

Report from the First EPIICAL (Early-treated Perinatally HIV-infected Individuals: Improving Children's Actual Life with Novel Immunotherapeutic Strategies) General Assembly meeting, 9-11 November 2017, Rome, Italy.

Zangari P, Palma P, Cotugno N, Rojo P, Tagarro A, Pepponi I, De Rossi A, Kuhn L, Pahwa S, Cameron M, Nastouli E, Watters S, Marceline AG, McCoy LE, Persaud D, Violari A, Chan M, Babiker AG, Foster C, Ananworanich J, Giaquinto C, Rossi P.

J Virus Erad. 2018 Jan 1;4(1):51-54. No abstract available.

2.

Childhood adversity increases the risk of onward transmission from perinatal HIV-infected adolescents and youth in South Africa.

Kidman R, Nachman S, Dietrich J, Liberty A, Violari A.

Child Abuse Negl. 2018 May;79:98-106. doi: 10.1016/j.chiabu.2018.01.028. Epub 2018 Feb 20.

PMID:
29428881
3.

Routine viral load monitoring in HIV-infected infants and children in low- and middle-income countries: challenges and opportunities.

Arpadi SM, Shiau S, De Gusmao EP, Violari A.

J Int AIDS Soc. 2017 Nov;20 Suppl 7. doi: 10.1002/jia2.25001.

PMID:
29171190
4.

Use of Multiplex Quantitative PCR To Evaluate the Impact of Pneumococcal Conjugate Vaccine on Nasopharyngeal Pneumococcal Colonization in African Children.

Olwagen CP, Adrian PV, Nunes MC, Groome MJ, Cotton MF, Violari A, Madhi SA.

mSphere. 2017 Nov 8;2(6). pii: e00404-17. doi: 10.1128/mSphere.00404-17. eCollection 2017 Nov-Dec.

5.

Neuropsychological performance in African children with HIV enrolled in a multisite antiretroviral clinical trial.

Boivin MJ, Barlow-Mosha L, Chernoff MC, Laughton B, Zimmer B, Joyce C, Bwakura-Dangarembizi M, Ratswana M, Abrahams N, Fairlie L, Gous H, Kamthunzi P, McCarthy K, Familiar-Lopez I, Jean-Phillippe P, Coetzee J, Violari A, Cotton MC, Palumbo PE; IMPAACT P1104s Study Team.

AIDS. 2018 Jan 14;32(2):189-204. doi: 10.1097/QAD.0000000000001683.

PMID:
29112069
6.

Dating Violence Against HIV-Infected Youth in South Africa: Associations With Sexual Risk Behavior, Medication Adherence, and Mental Health.

Kidman R, Violari A.

J Acquir Immune Defic Syndr. 2018 Jan 1;77(1):64-71. doi: 10.1097/QAI.0000000000001569.

PMID:
29040165
7.

Thymic Output and CD4 T-Cell Reconstitution in HIV-Infected Children on Early and Interrupted Antiretroviral Treatment: Evidence from the Children with HIV Early Antiretroviral Therapy Trial.

Lewis J, Payne H, Walker AS, Otwombe K, Gibb DM, Babiker AG, Panchia R, Cotton MF, Violari A, Klein N, Callard RE.

Front Immunol. 2017 Sep 20;8:1162. doi: 10.3389/fimmu.2017.01162. eCollection 2017.

8.

Immunogenicity of 13-valent pneumococcal conjugate vaccine among children with underlying medical conditions.

Jallow S, Madhi SA, Madimabe R, Sipambo N, Violari A, Kala U, Petersen K, Naidoo S, Verwey C, Moore DP, Nunes MC.

Vaccine. 2017 Aug 3;35(34):4321-4329. doi: 10.1016/j.vaccine.2017.06.081. Epub 2017 Jul 5.

PMID:
28688781
9.

A retrospective case-cohort study comparing treatment outcomes in abacavir versus stavudine containing first line antiretroviral treatment regimens in children <3yrs old, at a paediatric programme based in Soweto, South Africa.

Cassim H, Otwombe K, Lazarus E, Liberty A, Gray GE, Greeff OBW, Violari A.

PLoS One. 2017 Jul 7;12(7):e0180645. doi: 10.1371/journal.pone.0180645. eCollection 2017.

10.

Patterns of Growth, Body Composition, and Lipid Profiles in a South African Cohort of Human Immunodeficiency Virus-Infected and Uninfected Children: A Cross-Sectional Study.

Ramteke SM, Shiau S, Foca M, Strehlau R, Pinillos F, Patel F, Violari A, Liberty A, Coovadia A, Kuhn L, Arpadi SM; CHANGES Study Team.

J Pediatric Infect Dis Soc. 2017 May 6. doi: 10.1093/jpids/pix026. [Epub ahead of print]

PMID:
28481997
11.

Second- and Third-line Antiretroviral Therapy for Children and Adolescents: A Scoping Review.

Lazarus E, Nicol S, Frigati L, Penazzato M, Cotton MF, Centeno-Tablante E, Violari A, Nicol L.

Pediatr Infect Dis J. 2017 May;36(5):492-499. doi: 10.1097/INF.0000000000001481. Review.

PMID:
28403052
12.

Impact of HIV and Atiretroviral Therapy on Neurocognitive Outcomes Among School-Aged Children.

Brahmbhatt H, Boivin M, Ssempijja V, Kagaayi J, Kigozi G, Serwadda D, Violari A, Gray RH.

J Acquir Immune Defic Syndr. 2017 May 1;75(1):1-8. doi: 10.1097/QAI.0000000000001305.

PMID:
28169874
13.

Use of antiretrovirals in HIV-infected children in a tuberculosis prevention trial: IMPAACT P1041.

Zeldow B, Kim S, McSherry G, Cotton MF, Jean-Philippe P, Violari A, Bobat R, Nachman S, Mofenson LM, Madhi SA, Mitchell C.

Int J Tuberc Lung Dis. 2017 Jan 1;21(1):38-45. doi: 10.5588/ijtld.16.0149.

14.

Extent of disclosure: what perinatally HIV-infected children have been told about their own HIV status.

Murnane PM, Sigamoney SL, Pinillos F, Shiau S, Strehlau R, Patel F, Liberty A, Abrams EJ, Arpadi S, Coovadia A, Violari A, Kuhn L.

AIDS Care. 2017 Mar;29(3):378-386. doi: 10.1080/09540121.2016.1224310. Epub 2016 Aug 29.

15.

Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention.

Fowler MG, Qin M, Fiscus SA, Currier JS, Flynn PM, Chipato T, McIntyre J, Gnanashanmugam D, Siberry GK, Coletti AS, Taha TE, Klingman KL, Martinson FE, Owor M, Violari A, Moodley D, Theron GB, Bhosale R, Bobat R, Chi BH, Strehlau R, Mlay P, Loftis AJ, Browning R, Fenton T, Purdue L, Basar M, Shapiro DE, Mofenson LM; IMPAACT 1077BF/1077FF PROMISE Study Team.

N Engl J Med. 2016 Nov 3;375(18):1726-1737.

16.

Nevirapine- Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy in HIV-Infected Infants and Young Children: Long-term Follow-up of the IMPAACT P1060 Randomized Trial.

Barlow-Mosha L, Angelidou K, Lindsey J, Archary M, Cotton M, Dittmer S, Fairlie L, Kabugho E, Kamthunzi P, Kinikar A, Mbengeranwa T, Msuya L, Sambo P, Patel K, Barr E, Jean-Phillipe P, Violari A, Mofenson L, Palumbo P, Chi BH.

Clin Infect Dis. 2016 Oct 15;63(8):1113-1121. doi: 10.1093/cid/ciw488. Epub 2016 Jul 20.

17.

Source case identification in HIV-exposed infants and tuberculosis diagnosis in an isoniazid prevention study.

Maritz ER, Montepiedra G, Liu L, Mitchell CD, Madhi SA, Bobat R, Violari A, Ogwu A, Hesseling AC, Cotton MF.

Int J Tuberc Lung Dis. 2016 Aug;20(8):1060-4. doi: 10.5588/ijtld.15.0602.

18.

Low Vitamin-D Levels Combined with PKP3-SIGIRR-TMEM16J Host Variants Is Associated with Tuberculosis and Death in HIV-Infected and -Exposed Infants.

Gupta A, Montepiedra G, Gupte A, Zeldow B, Jubulis J, Detrick B, Violari A, Madhi S, Bobat R, Cotton M, Mitchell C, Spector S; IMPAACT NWCS113 and P1041 Study Team.

PLoS One. 2016 Feb 12;11(2):e0148649. doi: 10.1371/journal.pone.0148649. eCollection 2016.

19.

Understanding NIH clinical case definitions for pediatric intrathoracic TB by applying them to a clinical trial.

Beneri CA, Aaron L, Kim S, Jean-Philippe P, Madhi S, Violari A, Cotton MF, Mitchell C, Nachman S; P1041 team.

Int J Tuberc Lung Dis. 2016 Jan;20(1):93-100. doi: 10.5588/ijtld.14.0848.

20.

Early ART Results in Greater Immune Reconstitution Benefits in HIV-Infected Infants: Working with Data Missingness in a Longitudinal Dataset.

Azzoni L, Barbour R, Papasavvas E, Glencross DK, Stevens WS, Cotton MF, Violari A, Montaner LJ.

PLoS One. 2015 Dec 15;10(12):e0145320. doi: 10.1371/journal.pone.0145320. eCollection 2015.

Supplemental Content

Loading ...
Support Center